About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:8329983
Allelic
Composition
Hgsnatem1Scher/Hgsnatem1Scher
Genetic
Background
C57BL/6J-Hgsnatem1Scher
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Hgsnatem1Scher mutation (0 available); any Hgsnat mutation (39 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
behavior/neurological
• mice show an inability to properly couple the movement of the right front paw with the left hind paw and defects in support diagonal, run average speed, duration, and run duration on the CatWalk testing apparatus
• wild-type HSPC transplantation into lethally irradiated homozygotes at 2 months of age improves the gait and locomotor function impairments
• 10-month-old mice show increased mean speed and distance in the open field
• however, time spend in the center, thigmotaxis, and freezing time show no differences

cellular
• microglial activation is seen the brain, kidney, and liver

growth/size/body
• mice exhibit enlarged bladder
• bladder size is reduced following transplantation with wild-type HPSCs
• hepatomegaly
• transplantation with wild-type HPSCs does not improve hepatomegaly
• increase in spleen mass indicating splenomegaly
• spleen mass is decreased following transplantation with wild-type HPSCs

hematopoietic system
• microglial activation is seen the brain, kidney, and liver
• increase in spleen mass indicating splenomegaly
• spleen mass is decreased following transplantation with wild-type HPSCs

homeostasis/metabolism
• mice show accumulation of total heparan sulfate within the brain and kidney and the presence of MPS IIC disease-specific non-reducing end carbohydrates in the liver and brain
• single systemic wild-type hematopoietic stem and progenitor cell (HSPC) transplantation into lethally irradiated homozygotes at 2 months of age decreases the MPS IIC disease-specific non-reducing end carbohydrates

immune system
• microglial activation is seen the brain, kidney, and liver
• increase in spleen mass indicating splenomegaly
• spleen mass is decreased following transplantation with wild-type HPSCs
• CD68 expression is increased in the brain indicating macrophage/microglia activation and phagocytic activity
• CD68 expression is reduced following transplantation with wild-type HPSCs
• an increase of CD68+ cells is seen in the liver suggesting an increase of liver inflammation
• CD68+ cells in the liver are reduced following transplantation with wild-type HPSCs
• an increase of CD68+ cells is seen in the kidney suggesting an increase of kidney inflammation
• CD68+ cells in the kidney are reduced following transplantation with wild-type HPSCs

liver/biliary system
• hepatomegaly
• transplantation with wild-type HPSCs does not improve hepatomegaly
• an increase of CD68+ cells is seen in the liver suggesting an increase of liver inflammation
• CD68+ cells in the liver are reduced following transplantation with wild-type HPSCs

nervous system
• microglial activation is seen the brain, kidney, and liver
• CD68 expression is increased in the brain indicating macrophage/microglia activation and phagocytic activity
• CD68 expression is reduced following transplantation with wild-type HPSCs
• increase in neurofilament light chain (NfL) serum levels indicating neuronal damage
• NfL serum levels are decreased following transplantation with wild-type HPSCs

renal/urinary system
• mice exhibit enlarged bladder
• bladder size is reduced following transplantation with wild-type HPSCs
• an increase of CD68+ cells is seen in the kidney suggesting an increase of kidney inflammation
• CD68+ cells in the kidney are reduced following transplantation with wild-type HPSCs
• kidney shows glomerular hyaline bodies with focal fibrosis and sclerosis
• the number of damaged glomeruli is reduced following transplantation with wild-type HPSCs
• kidney shows sclerosis
• kidney shows focal fibrosis
• kidney shows some dilated tubules and vascular spaces
• urine retention
• urine volume is reduced following transplantation with wild-type HPSCs

mortality/aging
N
• normal number of homozygotes are obtained and no difference in life span is seen up to 15 months of age

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
mucopolysaccharidosis type IIIC DOID:0111393 OMIM:252930
J:381685


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
05/12/2026
MGI 6.24
The Jackson Laboratory